The protein is purified under denaturing conditions and stabilized in Tris/PBS buffer with 6% trehalose (pH 8.0) to prevent aggregation. Functional assays remain limited due to the protein’s uncharacterized role in ABV biology .
| Parameter | Specification |
|---|---|
| Form | Lyophilized powder |
| Solubility | Reconstitutes in deionized water (0.1–1.0 mg/mL) |
| Stabilizers | 6% trehalose; glycerol (optional for long-term storage) |
| Endotoxin Levels | <1.0 EU/μg (upon request) |
| Storage | -20°C/-80°C; avoid repeated freeze-thaw cycles |
ORF92 is encoded by the ABV genome, a 23.8-kb linear dsDNA virus with 57 open reading frames (ORFs). Key genomic features:
Membrane protein studies: Structural analysis of archaeal viral transmembrane domains under acidic, high-temperature conditions .
Antigen production: Potential use in antibody generation for ABV detection in environmental samples .
Comparative virology: Investigating evolutionary links between archaeal and bacterial/eukaryotic viruses .
KEGG: vg:5129806
The Acidianus bottle-shaped virus (ABV) infects strains of hyperthermophilic archaea belonging to the genus Acidianus and possesses a morphology entirely distinct from all other characterized viruses. Its genomic structure consists of linear double-stranded DNA containing 23,814 base pairs with a G+C content of 35% and exhibits a 590-bp inverted terminal repeat. The virus has been taxonomically assigned to the family Ampullaviridae based on its unique characteristics. The scientific significance of ABV lies in its exceptional isolation environment (hot acidic springs at 93°C, pH 1.5) and its genomic organization, which reveals potential evolutionary links between archaeal, bacterial, and eukaryotic viruses. Of particular interest, one region at the end of the ABV linear genome shows similarities in both gene content and organization to corresponding regions in bacteriophage φ29 and human adenovirus, suggesting possible shared mechanisms of DNA replication and packaging .
The ORF92 protein is a putative transmembrane protein encoded by the Acidianus bottle-shaped virus genome. It consists of 92 amino acids with the following sequence: MSLIGLDLFDFVKGIVLLALTSGATYAIGKQFFSSNYCAIARIIQALLLFASSFLFDSAGALILGVIVLIIGVGNYLAETNSKFAFLDPNLA. The protein has a molecular weight of approximately 9,754 Da and is predicted to contain transmembrane domains, as indicated by its classification as a putative transmembrane protein . The gene encoding this protein is located at position NC_009452.1 (11839..12117) in the ABV genome. Computational structural analysis is available through ModBase for the protein (UniProt ID: A4ZUB3), providing researchers with predicted three-dimensional structural information that can inform functional hypotheses and experimental design .
Recombinant ORF92 can be successfully expressed in multiple heterologous systems, each with distinct advantages depending on your research objectives:
| Expression System | Advantages | Considerations | Recommended Applications |
|---|---|---|---|
| E. coli | High yield, rapid growth, cost-effective, well-established protocols | May lack post-translational modifications, potential inclusion body formation | Initial characterization, antibody production, structural studies |
| Yeast | Eukaryotic post-translational modifications, protein folding machinery, moderate cost | Longer expression time than bacteria, potential hyperglycosylation | Functional studies requiring some post-translational modifications |
| Baculovirus | Advanced eukaryotic post-translational modifications, suitable for toxic proteins | Technical complexity, higher cost, longer timeline | Complex functional assays, interaction studies |
| Mammalian Cell | Most sophisticated post-translational modifications, native-like protein folding | Highest cost, longest timeline, technical expertise required | Advanced functional studies, therapeutic applications |
Current literature indicates successful expression of ORF92 in E. coli with an N-terminal His-tag, achieving greater than 85-90% purity as determined by SDS-PAGE . When designing expression constructs, researchers should consider incorporating appropriate affinity tags (His, GST, MBP) to facilitate purification and detection while evaluating potential tag interference with protein function or structure. Expression optimization should include evaluation of different induction conditions, temperature, and media formulations to maximize soluble protein yield .
For investigating ORF92 function, a rigorous experimental design should employ multiple complementary approaches:
Single-Case Experimental Design (SCED): This approach provides researchers with a flexible alternative to large sample size group designs, particularly valuable when working with unique viral proteins like ORF92 where replication or resource constraints may limit sample numbers. SCED methodology involves repeated, systematic assessment of variables over time, with experimental control achieved through replication of effects either within or between experimental conditions. When implementing SCED for ORF92 studies, researchers should establish a representative baseline (minimum 3-5 data points per phase), address autocorrelation issues, and carefully interpret effect sizes .
Randomized Controlled Experimental Design: For comparative studies evaluating ORF92 against mutant variants or other viral proteins, a randomized controlled design enhances methodological rigor and internal validity. This approach is particularly important when determining causality between ORF92 structural elements and functional outcomes .
Functional Genomics Approaches: Combining protein expression with genomic analyses can provide insights into ORF92's role within the ABV replication cycle. This might include transcriptomic analysis of host cells during infection, proteomics to identify interaction partners, or CRISPR-based screening to identify host factors required for ORF92 function.
The experimental framework should clearly define:
Independent variables (e.g., protein mutations, environmental conditions)
Dependent variables (e.g., membrane integration, protein-protein interactions)
Control conditions
Measurement techniques and timepoints
Statistical analysis methods appropriate for the data structure
Researchers should also consider the extreme environmental conditions of the native virus (93°C, pH 1.5) when designing functional assays to ensure physiological relevance .
Structural characterization of ORF92 presents unique opportunities to elucidate adaptation mechanisms of viruses to extreme environments. As a transmembrane protein from a hyperthermophilic archaeal virus that thrives at 93°C and pH 1.5, ORF92 likely possesses structural features that confer exceptional thermostability and acid resistance .
Advanced structural studies should incorporate:
X-ray Crystallography/Cryo-EM Analysis: Determining the three-dimensional structure at high resolution can reveal unique folding patterns, stabilizing interactions, and functional domains. This requires optimization of crystallization conditions under native-like environments.
Molecular Dynamics Simulations: Computational modeling of ORF92 behavior under extreme temperature and pH conditions can identify key stabilizing interactions and conformational changes. These simulations should be validated against experimental data.
Comparative Structural Analysis: Comparing ORF92's structure with transmembrane proteins from mesophilic viruses can highlight specific adaptations to extreme environments. This approach should utilize the ModBase 3D structure prediction for A4ZUB3 as a starting point .
Site-Directed Mutagenesis Combined with Stability Assays: Systematic mutation of candidate stabilizing residues followed by thermal stability assays can experimentally validate structural predictions. This approach should particularly focus on regions with unusual amino acid distributions compared to mesophilic homologs.
These structural insights could potentially reveal novel protein engineering principles applicable to biotechnology applications requiring extreme condition stability, such as industrial enzymes or therapeutic proteins with extended shelf-life .
The ABV genome contains a region remarkably similar in both gene content and organization to corresponding regions in bacteriophage φ29 and human adenovirus, specifically encoding a putative protein-primed DNA polymerase and a small putative RNA with predicted secondary structure resembling the prohead RNA of bacteriophage φ29 . This evolutionary connection represents a fascinating area for investigation using several methodological approaches:
These approaches can provide evidence for or against the hypothesis of a primordial gene pool as the source of viral genes, potentially revealing fundamental insights into viral evolution across domains of life .
Researchers working with recombinant ORF92 frequently encounter several technical challenges during expression and purification. The table below summarizes these challenges and provides methodological solutions:
| Challenge | Potential Causes | Recommended Solutions | Validation Approaches |
|---|---|---|---|
| Low soluble expression | Transmembrane nature of ORF92, improper folding, toxic effects | - Use specialized E. coli strains (e.g., C41(DE3), C43(DE3)) designed for membrane proteins - Express at lower temperatures (16-20°C) - Include mild detergents (0.1% DDM, CHAPS) in lysis buffer - Consider fusion with solubility-enhancing tags (MBP, SUMO) | Western blot comparing soluble vs. insoluble fractions; fluorescence-based protein folding assays |
| Protein aggregation | Hydrophobic interactions, improper refolding, loss of structural stability | - Include stabilizing agents (10% glycerol, 50-200 mM NaCl) - Optimize detergent type and concentration - Implement step-wise dialysis for refolding - Use size exclusion chromatography as final purification step | Dynamic light scattering; size exclusion chromatography; thermal shift assays |
| Poor affinity purification | Tag inaccessibility, non-specific binding, tag interference | - Increase linker length between protein and tag - Optimize imidazole concentration gradient - Add low concentrations of detergents to reduce non-specific binding - Consider dual tagging strategies | SDS-PAGE analysis of elution fractions; western blot with anti-tag antibodies |
| Degradation during storage | Protease contamination, thermally-induced unfolding | - Add protease inhibitors during purification - Store at -80°C in small aliquots - Add 6% trehalose in Tris/PBS-based storage buffer (pH 8.0) - Avoid repeated freeze-thaw cycles | Time-course stability analysis by SDS-PAGE; activity assays after various storage conditions |
When optimizing ORF92 purification, researchers should implement systematic parameter variation rather than changing multiple variables simultaneously. Recombinant ORF92 should be reconstituted in deionized sterile water to a concentration of 0.1-1.0 mg/mL, with the addition of 5-50% glycerol (final concentration) for long-term storage at -20°C/-80°C .
Designing appropriate controls is critical for rigorous functional characterization of ORF92. A comprehensive control strategy should include:
Negative Controls:
Expression vector without the ORF92 insert, processed identically to the experimental samples
Structurally similar but functionally distinct transmembrane proteins from other viruses
Heat-denatured ORF92 (particularly relevant given its thermophilic origin)
Positive Controls:
Well-characterized transmembrane proteins with known functions and measurable activities
If specific functions are hypothesized, proteins with similar confirmed functions
Internal Controls:
Site-directed mutants of ORF92 targeting predicted functional domains
Tagged versions of ORF92 with different fusion partners to control for tag effects
Dose-response experiments at varying protein concentrations
Environmental Controls:
Experimental conditions mimicking the native environment (pH 1.5, 93°C) compared to standard conditions
Buffer composition controls to account for ions, detergents, or stabilizing agents
For single-case experimental designs (SCED), establishing a representative baseline is crucial, with a minimum of 3-5 data points recommended in each phase of the experiment . Additionally, researchers should consider randomization components to improve methodological rigor and internal validity .
Advancing our understanding of ORF92's function within ABV biology requires innovative experimental approaches that address the unique challenges of studying extremophilic archaeal viruses:
Cryo-Electron Tomography: Visualizing ABV virions with ORF92 specifically labeled (via nanobodies or minimal tags) could determine the protein's localization and arrangement within the viral particle, providing structural insights into its functional role.
Synthetic Biology Approaches: Reconstructing minimal ABV systems with systematically varied components could reveal essential functions of ORF92 in viral assembly, host recognition, or genome packaging. This could involve creating chimeric viruses where ORF92 is replaced with homologs from other systems.
Advanced Imaging of Host-Virus Interactions: Implementing super-resolution microscopy techniques to track fluorescently-tagged ORF92 during the viral infection cycle could elucidate its temporal and spatial distribution, particularly its potential role in membrane interactions.
Systems Biology Integration: Combining proteomics, transcriptomics, and metabolomics to characterize host responses to wild-type versus ORF92-mutant viruses could identify pathways affected by this protein, providing functional insights through indirect evidence.
Microfluidic High-Throughput Screening: Developing specialized high-throughput screening platforms adapted to extreme conditions could enable testing of ORF92 interactions with libraries of compounds or peptides, potentially revealing binding partners or inhibitors.
These approaches should be designed using rigorous experimental frameworks, incorporating appropriate controls and statistical analyses as outlined in contemporary experimental design standards .
Comparative analysis of ORF92 with transmembrane proteins from other extremophilic viruses represents a valuable approach to refining viral taxonomy and evolutionary models. This research direction should implement:
Expanded Phylogenomic Analysis: Constructing phylogenetic networks rather than simple trees to account for potential horizontal gene transfer events between viruses from different domains of life. This approach should incorporate the latest viral metagenomic data from extreme environments worldwide.
Structural Comparison Methodology: Developing quantitative metrics for comparing structural adaptations to extreme environments across diverse viral lineages, focusing on transmembrane domains that interact directly with challenging environmental conditions.
Experimental Reconstruction of Ancestral Sequences: Utilizing ancestral sequence reconstruction algorithms to predict evolutionary precursors of ORF92, followed by laboratory resurrection and functional testing of these predicted ancestors to validate evolutionary models.
Horizontal Gene Transfer Analysis: Implementing computational approaches to detect potential horizontal gene transfer events that might explain the observed similarities between ABV genes and those of bacteriophage φ29 and human adenovirus, particularly focused on the DNA replication machinery.
The apparent similarities in putative mechanisms of DNA replication and packaging between ABV and viruses from bacterial and eukaryotic hosts suggest a potential primordial gene pool as a source of viral genes . Testing this hypothesis requires integration of computational predictions with experimental validation through the approaches outlined above.